CAREDX, INC. Debt Conversion, Converted Instrument, Amount
CAREDX, INC. (CDNA) reported Debt Conversion, Converted Instrument, Amount of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2021-02-24
- CAREDX, INC. debt conversion, converted instrument, amount for fiscal 2020 was $0.00.
- CAREDX, INC. debt conversion, converted instrument, amount for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- CAREDX, INC. debt conversion, converted instrument, amount for fiscal 2018 was $38.85M.
- CAREDX, INC. debt conversion, converted instrument, amount for fiscal 2017 was $0.00.
| Period end | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-24 |
| 2019-12-31 | $0.00 10-K · filed 2021-02-24 |
| 2018-12-31 | $38.85M 10-K · filed 2021-02-24 |
| 2017-12-31 | $0.00 10-K · filed 2020-02-28 |
| 2016-12-31 | $0.00 10-K · filed 2019-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |